Department of Neurosurgery, University Hospital Leipzig, Liebigstrasse 20, 04103, Leipzig, Germany.
Department of Neurology, University Hospital Leipzig, Liebigstrasse 20, 04103, Leipzig, Germany.
Acta Neurochir (Wien). 2019 Sep;161(9):1853-1864. doi: 10.1007/s00701-019-04004-1. Epub 2019 Jul 11.
Feasibility and value of non-invasive transcranial magnetic brain stimulation (TMS MAGVENTURE® MagPro R30 Denmark) for preoperative diagnosis and surgical planning of brain tumor operations in everyday clinical practice.
A prospective monocentric study was conducted, which included preoperative neurological and electrophysiological examination, TMS, and display of functional data in the navigation system (LOCALITE® TMS Navigator Germany). During surgery, the TMS data were correlated with the intraoperative monitoring (IOM). Twenty-four hours to 96 h and after at least 3 months, follow-ups with neurological, electrophysiological examinations and TMS stimulation were performed.
Twenty-five patients with tumors in or near by the primary motor cortex region were included in the study. Twenty-one patients completed preoperative and first postoperative TMS and the neurological examination. Eight of 21 patients showed slight worsening of primary motor cortex function, 8 patients had an unchanged state, and 4 patients showed an improvement early after surgery. The changes of the electrophysiological examination like significant delay of the latency and/or reduced amplitudes matched well with the postoperative neurological outcome: if patients showed a worsening of the SEP's and MEP's, the postoperative results revealed deterioration.
A preoperatively performed TMS using the MAGVENTURE® MagPro R30 and the LOCALITE® TMS Navigator could be established in our clinical daily practice and allowed a safe and reliable mapping of the primary motor cortex in order to minimize the risk of postoperative neurological deficits and improve the neurological outcome of the patients.
在日常临床实践中,探讨非侵入性经颅磁刺激(TMS MAGVENTURE® MagPro R30 Denmark)在脑肿瘤手术术前诊断和手术计划中的可行性和价值。
进行了一项前瞻性单中心研究,该研究包括术前神经和电生理检查、TMS 以及导航系统中功能数据的显示(德国 LOCALITE® TMS Navigator)。在手术过程中,将 TMS 数据与术中监测(IOM)相关联。在术后 24 小时至 96 小时以及至少 3 个月后,进行神经学、电生理检查和 TMS 刺激的随访。
本研究纳入了 25 例肿瘤位于或靠近初级运动皮层区域的患者。21 例患者完成了术前和第一次术后 TMS 和神经检查。8 例患者表现出轻微的初级运动皮层功能恶化,8 例患者表现为无变化,4 例患者术后早期表现出改善。电生理检查的变化,如潜伏期显著延迟和/或幅度降低,与术后神经学结果相匹配:如果患者的 SEP 和 MEP 恶化,术后结果显示恶化。
在我们的临床日常实践中,使用 MAGVENTURE® MagPro R30 和 LOCALITE® TMS Navigator 进行术前 TMS 可以安全可靠地对初级运动皮层进行定位,以最大限度地降低术后神经功能缺损的风险,并改善患者的神经学结果。